Alex Hatzimanolis Selected Research

Complement C4a

10/2022

Deregulation of complement components C4A and CSMD1 peripheral expression in first-episode psychosis and links to cognitive ability.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alex Hatzimanolis Research Topics

Disease

5	Psychotic Disorders (Schizoaffective Disorder) 01/2024 - 01/2020
4	Schizophrenia (Dementia Praecox) 01/2024 - 10/2008
1	Genetic Risk Score 01/2024
1	Dementia (Dementias) 01/2022
1	Cognitive Dysfunction 01/2022
1	Mental Disorders (Mental Disorder) 01/2021
1	Mood Disorders (Mood Disorder) 06/2013
1	Multiple Sclerosis 02/2008

Drug/Important Bio-Agent (IBA)

4	Polytetrafluoroethylene (Teflon)FDA Link 01/2024 - 01/2020
2	Antipsychotic Agents (Antipsychotics)IBA 10/2022 - 01/2020
1	25-hydroxyvitamin DIBA 01/2024
1	Vitamin D FDA LinkGeneric 01/2024
1	Complement System Proteins (Complement)IBA 10/2022
1	Complement C4aIBA 10/2022
1	Messenger RNA (mRNA)IBA 10/2022
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2022
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022
1	DiureticsIBA 01/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	Angiotensin Receptor AntagonistsIBA 01/2022
1	Nootropic Agents (Nootropics)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 06/2013
1	GTP-Binding Proteins (G-Protein)IBA 10/2008
1	Glutamic Acid (Glutamate)FDA Link 02/2008
1	Ionotropic Glutamate ReceptorsIBA 02/2008

Therapy/Procedure

1	Therapeutics 01/2022